FDA updates guidance to reflect advances in technology.

Novartis? half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.

Takeda's drug vedolizumab is granted priority review status for the treatment of adults with moderately to severely active ulcerative colitis.

New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.

Cargill invests to upgrade its alginate production plant in in Lannilis, Brittany, France.

MPI's new Imaging Center is set to open in Spring 2014 at the company's headquarters in Michigan.

An FDA Committee voted to support approval of GSK and Theravance?s umeclidinium/vilanterol for treatment of chronic pulmonary disease.

FDA specifies the DUNS UFI system for registration of domestic and foreign drug establishments.

The association representing the research-based pharmaceutical industry in Europe is concerned that an EMA policy will put transparency ahead of public-health interests.

FDA revises boxed warnings for extended-release and long-acting opioid analgesics and postmarket study requirements.

VWR International has signed a global distribution agreement with Thermo Fisher Scientific.

Horizon Pharma reports that FDA has approved the use of Sanofi's manufacturing site in Compiegne, France to manufacture DUEXIS.

Myriad Genetics and AstraZeneca expand their companion diagnostic pact for AztraZeneca?s investigational drug candidate olaparib.

Regulatory Authorities Discuss Elemental Impurities Standards

Mylan completes expansion of its transdermal patch facility in Vermont.

Sanofi and POZEN sign a license agreement for the commercialization of omeprazole and aspirin combination product.

FDA inspections reveal possible inaccurate sterility testing.

Following passage in the California Assembly, the California State Senate passes legislation to specify requirements for dispensing biosimilars.

Otsuka's planned acquisition bolsters its pipeline in oncology and adds fragment-based drug-discovery technology.

Rockwell Collins will sell Kaiser Optical Systems to Endress+Hauser.

Meda will acquire Acton Pharmaceuticals.

BioReliance opens Clearance Services Laboratories in Maryland for downstream bioprocessing studies.

Endo will acquire Boca Pharmacal in multimillion dollar deal.

Agilent Technologies opens multimillion dollar Spectroscopy Technology Innovation Center in Australia.

CordenPharma will acquire Peptisyntha SA, based in Belgium.

FDA approves BD Simplist product ondansetron injection, an injectable antiemetic.

Merck & Co gets FDA approval to manufacture bulk varicella at its in Durham, North Carolina for use in chickenpox and shingles vaccines.

Zealand will join efforts with Eli Lilly to design and develop therapeutic peptides for Type 2 diabetes and obesity.